Document is current
Any future updates will be listed below
-
Authors
Jiang, Yixiang
Lin, Yan
Tetlow, Amber M.
Pan, Ruimin
Ji, Changyi
Kong, Xiang-Peng
Congdon, Erin E.
Sigurdsson, Einar M. https://orcid.org/0000-0003-1451-0952
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (R21 AG059391, R01 AG032611, R01 NS077239, RF1 NS120488, R56 AG083436-01)
Alzheimer’s Association (AARF-22-924783)
- License Information
-
More Information
Article History
Received: 19 December 2023
Accepted: 6 May 2024
First Online: 31 May 2024
Declarations
:
: Any data derived from human tissue would not include any patient identifiers. This study was conducted in accordance with US ethical guidelines and was deemed exempt from ethics approval by the Institutional Review Board (IRB). All mouse experiments were performed under an institutional animal care and use committee (IACUC) approved protocol with the mice housed in Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) approved facilities with access to food and water ad libitum.
: Not applicable.
: E.M.S. is an inventor on a patent application related to the initial development of anti-α-syn sdAbs filed by New York University (no. PCT/US2019/018579, filed 19 February 2019 and published 22 August 2019). The authors declare that they have no other competing interests.
